Memry Corporation (AMEX: MRY), a provider of design, engineering, development and manufacturing services to the medical device and other industries focusing on the company’s proprietary shape-memory alloy and polymer extrusion technologies, recently announced that the company’s chief executive officer, Robert Belcher, presented at the Noble Financial Capital Markets M.A.D. MAX Equity Conference in Las Vegas, Nevada.
During the presentation, Mr. Belcher explained that the company has a strong growing pipeline and solid balance sheet. Additionally, he stated that the company is generating momentum and is investing in areas to generate revenue growth. The medical device market is expected to reach $11 billion by the year 2011. Medical device products include stent components, catheter components, guidewires, laparoscopic surgical sub-assemblies and orthopedic instruments. The rapid growth of this market has increased outsourcing for device manufacturing.
Memry Corporation is currently pursuing acquisition opportunities that will allow the company to expand its scope with unique technologies that are patent-protected. In addition, the company is currently investing in development projects, new technologies and sales and marketing initiatives. Given the current state of the economy, management is cognizant of expenses and is always looking for areas to improve costs and achieve process efficiencies.
Let us hear your thoughts below: